Hepatocellular Carcinoma Clinical Trials in Dresden
3 recruitingDresden, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Not Applicable
The Dragon PLC Trial (DRAGON-PLC)
CholangiocarcinomaHepatocellular Carcinoma (HCC)Primary Liver Cancer
Maastricht University358 enrolled55 locationsNCT06914648
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994